VigorMeds NAD+ prices
4 figures read September 2026.
Every NAD+ figure VigorMeds publishes is a floor — a “from” or “starting at” price, $59–$199 at the bottom — so the number on the page is where its range begins and not necessarily a price anyone is charged.
What VigorMeds publishes
VigorMeds publishes only a floor — a “from” or “starting at” figure, which is the bottom of a range and not a price anyone is necessarily charged. Of the 29 sellers in this index that fall in the same bucket, that puts it with the 27% of the roster that publishes this shape of number rather than another one. A standing rate charged on a calendar month is the only figure this site treats as a monthly price, and 60 of the 106 sellers in this index — including this one — do not publish one.
The headline figures here do not all mean the same thing: this seller's 4 leading figures carry 2 different qualifiers between them — from-price, no cycle stated; from-price, “per month”. A board that printed them in one column would be comparing from-price, so this page prints each one with the sentence that makes it true.
Every figure VigorMeds publishes — 4 figures, read September 2026
| Figure | What it is | Cycle, in their words | Route | Dose | Read |
|---|---|---|---|---|---|
| $199 | from-price | no cycle stated | Patch | 400mg/ml | September 2026 |
| $69 | from-price | “per month” | Nasal | 150mg/ml (30ml) | September 2026 |
| $119 | from-price | “per month” | SubQ | 100mg/ml (10ml vial) | September 2026 |
| $59 | from-price | “per month” | Topical | Not stated | September 2026 |
In VigorMeds’s own words
- $199 from-price
The page says: “from $199 for 6 patches”
NAD+ Patches - a transdermal patch, which none of the four route buckets (iv / subcutaneous / nasal / oral-precursor) covers, so route is 'unspecified'. The page calls it 'A needle-free alternative that may help support NAD+ levels'. The unit is a 6-patch pack, not a time period, so cycleVerbatim is null; the pack size is inside the qualifier. This is the only NAD card with no '$50 off' badge.
Read from https://vigormeds.com/longevity/ on September 2026.
- $69 from-price
The page says: “$50 off from $69 per month”
The '$50 off' badge belongs to this card (it renders immediately above the price).
Read from https://vigormeds.com/longevity/ on September 2026.
- $119 from-price
The page says: “$50 off from $119 per month”
The page says 'Injections' and nothing more - it never writes subcutaneous, intramuscular or intravenous anywhere. Treated as at-home injection because Vigormeds is a mail-order telehealth catalog, but the seller does not state it.
Read from https://vigormeds.com/longevity/ on September 2026.
- $59 from-price
The page says: “$50 off from $59 per month”
NAD+ Face Cream - a topical, outside the four-route taxonomy, so route is 'unspecified'. It is the only NAD card with no strength line at all.
Read from https://vigormeds.com/longevity/ on September 2026.
Price disclosure score: 72 of 100
This scores what VigorMeds publishes about its price, and nothing else. It is not a rating of the product, the clinic, the prescriber or the value — this site has read a price page, not used a product. Across all 106 sellers in the index the scores run from 6 to 100, with a median of 72. VigorMeds sits 53 of 106.
| What is scored | What VigorMeds publishes | Points |
|---|---|---|
| An exact figure | The published figure is a floor — a “from” or “starting at” number, which is the bottom of a range and not necessarily a price anyone is charged. | 6of 30 |
| A stated cadence | The seller states the interval it bills on, so a reader knows when the next charge lands. | 20of 20 |
| Visible on the page | Every headline figure (4 figures) is printed where a reader can see it. | 20of 20 |
| A stated route | The seller states how the product is administered, in its own sentence. | 15of 15 |
| A stated dose | 3 of 4 figures state the dose they buy. | 11of 15 |
| Price disclosure score | This scores what the seller publishes about its price — not the product, the clinic, the prescriber or the value. | 72of 100 |
What VigorMeds does not publish
Each of these is a count over what was actually read, not an impression. 4 figures were read from this seller, and every sentence below is measured against that number.
- None of the 4 figures read from this seller is a standing rate charged by the calendar month.
Figures visible to a reader on the seller’s page
4 of 4
Figures stating a dose
3 of 4
Figures that resolve to a usable price
4 of 4
Source: Counted over the 4 figures read from VigorMeds’s own pages, September 2026. Each track is that figure count.
Where VigorMeds sits
66 other sellers in this index also state a Patch and Nasal and SubQ and Topical route. Ranked with them on price disclosure, VigorMeds is 46 of 67. That is a statement about how completely each one publishes a price, and about nothing else — the figures behind those rows are different kinds of number and several of them state no dose, so they are not a like-for- like price comparison and this site does not present them as one.
Boards VigorMeds appears on
The reading record
This site has read VigorMeds once, in September 2026. A movement can only be shown between two readings taken here, so there is nothing to show yet — and a single reading is a fact about this site's record, never a statement that the seller held its price.
Figures are read from VigorMeds’s own public pages and recorded with the date. What counts as a price, and why a “from” figure is recorded as a floor rather than a rate, is set out on the editorial policy page. Prices in this category move quietly, so the figure above is what the page said on September 2026 and not a promise about today.